GemVax & Kael
Daily close in US$ at the latest USD/KRW close. Source: KRX via FinanceDataReader.
GemVax & Kael is listed on KOSDAQ and classified under Industrials, Machinery. Its market value is US$334M. In FY2025 it reported revenue of US$61.5M and operating profit of US$2.9M.
A written company profile is not available yet; the facts above come from exchange and DART data.
GemVax & Kael in five facts
Where is GemVax & Kael listed and in which sector?
GemVax & Kael (Korean name: 젬백스) trades under KRX code 082270 on KOSDAQ, the Korea Exchange's board for smaller and growth companies. It is classified in the Industrials sector, Machinery.
How large is GemVax & Kael?
Its market capitalisation was US$334M on 2026-10-21, which puts it in this site's small-cap group. US$ amounts are converted from won at 1 USD ≈ ₩1,325 (2026-10-21).
What were GemVax & Kael's latest annual revenue and operating profit?
For fiscal year 2025, GemVax & Kael reported revenue of US$61.5M, operating profit of US$2.9M and a net loss of US$8.6M, per its annual report on DART (data retrieved from DART on 2026-09-17). Revenue was up 30.1% on the previous year.
Where does this data come from?
Financial statements and filings come from DART, Korea's official corporate-filing system. Share prices, market capitalisation and trading status come from KRX. Company summaries are AI-generated from the filings and may contain errors; financial figures are mapped directly from DART.
Data sources and last updated
- Filings and financial statements
- DART (dart.fss.or.kr), Korea's official corporate-filing system
- Prices, market cap, trading status
- KRX (Korea Exchange), via FinanceDataReader
- Latest annual financials
- Fiscal year 2025, data retrieved from DART on 2026-09-17
- Share price and market cap
- Close of 2026-10-21
- Currency
- US$, converted from won at 1 USD ≈ ₩1,325 (2026-10-21 close)
- Company data updated
- 2026-10-21
- Company summary
- AI-generated from filings; may contain errors. Information only, not investment advice.
- [Amended] Share-pledge agreement that may change the largest shareholder
GemVax & Kael's largest shareholder (Gem & Company Co., Ltd.) pledged shares as loan collateral to a financial company, securing up to US$50.2M.
Ownership change · Oct 19 - [Amended] Share-pledge agreement that may change the largest shareholder
GemVax & Kael's largest shareholder (Gem & Company Co., Ltd.) pledged shares as loan collateral to a financial company, securing up to US$49.1M.
Ownership change · Oct 1 - Report on securities held by executives/major shareholdersSep 18
- Report on securities held by executives/major shareholdersSep 18
- Report on securities held by executives/major shareholdersSep 18
- Report on securities held by executives/major shareholdersSep 18
- Report on securities held by executives/major shareholdersSep 18
- Treasury share disposal: results reportTreasury Shares · Sep 16
- [Amended] Securities issuance results (voluntary)Sep 14
- [Amended] Material event reportSep 11
- Material event report (treasury share disposal)
GemVax & Kael disclosed a plan to sell treasury shares worth US$1.45M, about 0.4% of its market value.
Treasury Shares · Sep 10 - Report on large shareholdings (5% rule) (standard)Sep 10
- Report on securities held by executives/major shareholdersSep 10
- Report on securities held by executives/major shareholdersSep 10
- [Amended] Material event report (rights offering)
GemVax & Kael updated the terms of convertible bonds to raise US$10.3M, about 2.8% of its market value.
Capital raise · Sep 4 - Report on large shareholdings (5% rule) (standard)Sep 1
- Report on securities held by executives/major shareholdersAug 31
- [Amended] Material event report (rights offering)
GemVax & Kael updated the terms of convertible bonds to raise US$10.1M, about 2.8% of its market value.
Capital raise · Aug 20 - [Amended] Share-pledge agreement that may change the largest shareholder
GemVax & Kael's largest shareholder (Gem & Company Co., Ltd.) pledged shares as loan collateral to a financial company, securing up to US$47.1M.
Ownership change · Aug 14 - [Amended] Material event report (rights offering)
GemVax & Kael updated the terms of convertible bonds to raise US$11.3M, about 3.2% of its market value.
Capital raise · Aug 13 - [Amended] Share-pledge agreement that may change the largest shareholder
GemVax & Kael's largest shareholder (Gem & Company Co., Ltd.) pledged shares as loan collateral to a financial company, securing up to US$47.1M.
Ownership change · Aug 12 - [Amended] Share-pledge agreement that may change the largest shareholder
GemVax & Kael's largest shareholder (Gem & Company Co., Ltd.) pledged shares as loan collateral to a financial company, securing up to US$48.3M.
Ownership change · Jul 30 - [Amended] Share-pledge agreement that may change the largest shareholder
GemVax & Kael's largest shareholder (Gem & Company Co., Ltd.) pledged shares as loan collateral to a financial company, securing up to US$47.2M.
Ownership change · Jul 28 - [Amended] Share-pledge agreement that may change the largest shareholder
GemVax & Kael's largest shareholder (Gem & Company Co., Ltd.) pledged shares as loan collateral to a financial company, securing up to US$47.6M.
Ownership change · Jul 24 - [Amended] Share-pledge agreement that may change the largest shareholder
GemVax & Kael's largest shareholder (Gem & Company Co., Ltd.) pledged shares as loan collateral to a financial company, securing up to US$48.8M.
Ownership change · Jul 20 - [Amended] Share-pledge agreement that may change the largest shareholder
GemVax & Kael's largest shareholder (Gem & Company Co., Ltd.) pledged shares as loan collateral to a financial company, securing up to US$48.5M.
Ownership change · Jul 15 - [Amended] Share-pledge agreement that may change the largest shareholder
GemVax & Kael's largest shareholder (Gem & Company Co., Ltd.) pledged shares as loan collateral to a financial company, securing up to US$50.1M.
Ownership change · Jun 19 - [Amended] Share-pledge agreement that may change the largest shareholder
GemVax & Kael's largest shareholder (Gem & Company Co., Ltd.) pledged shares as loan collateral to a financial company, securing up to US$50.9M.
Ownership change · Jun 15 - [Amended] Share-pledge agreement that may change the largest shareholder
GemVax & Kael's largest shareholder (Gem & Company Co., Ltd.) pledged shares as loan collateral to a financial company, securing up to US$50.8M.
Ownership change · Jun 2 - [Amended] Share-pledge agreement that may change the largest shareholder
GemVax & Kael's largest shareholder (Gem & Company Co., Ltd.) pledged shares as loan collateral to a financial company, securing up to US$51M.
Ownership change · Jun 1 - [Amended] Share-pledge agreement that may change the largest shareholder
GemVax & Kael's largest shareholder (Gem & Company Co., Ltd.) pledged shares as loan collateral to a financial company, securing up to US$52.7M.
Ownership change · May 22 - Material event report (convertible bonds)
GemVax & Kael disclosed convertible bonds to raise US$4.65M, about 1.4% of its market value.
Capital raise · May 22 - [Amended] Material event report (rights offering)
GemVax & Kael updated the terms of a private placement (third-party allotment) to raise US$11.3M, about 3.4% of its market value.
Capital raise · May 22 - [Amended] Share-pledge agreement that may change the largest shareholder
GemVax & Kael's largest shareholder (Gem & Company Co., Ltd.) pledged shares as loan collateral to a financial company, securing up to US$47.6M.
Ownership change · May 19 - [Amended] Share-pledge agreement that may change the largest shareholder
GemVax & Kael's largest shareholder (Gem & Company Co., Ltd.) pledged shares as loan collateral to a financial company, securing up to US$48.1M.
Ownership change · May 15 - [Amended] Share-pledge agreement that may change the largest shareholder
GemVax & Kael's largest shareholder (Gem & Company Co., Ltd.) pledged shares as loan collateral to a financial company, securing up to US$48.1M.
Ownership change · May 14 - [Amended] Share-pledge agreement that may change the largest shareholder
GemVax & Kael's largest shareholder (Gem & Company Co., Ltd.) pledged shares as loan collateral to a financial company, securing up to US$48.7M.
Ownership change · Apr 30 - Material event report (convertible bonds)
GemVax & Kael disclosed convertible bonds to raise US$5.98M, about 1.8% of its market value.
Capital raise · Apr 29 - Material event report (convertible bonds)
GemVax & Kael disclosed convertible bonds to raise US$4.98M, about 1.5% of its market value.
Capital raise · Apr 29 - Decision to acquire shares/equity in another company
GemVax & Kael disclosed an acquisition of Korea Stem Cell Bank Co., Ltd., worth US$8.42M.
M&A · Apr 28